中國旭陽集團(01907.HK)設合資旭陽偉山 在印尼投資建設年產480萬噸焦化項目
格隆匯7月15日丨中國旭陽集團(01907.HK)公吿,公司的全資附屬公司旭陽國際投資、旭陽國際與香港中偉及Dawn International於2021年7月15日訂立合資協議,據此,各方同意共同注資成立旭陽偉山,在印尼蘇拉威西青山工業園區內,合作投資建設年產480萬噸焦化項目。
旭陽國際投資、旭陽國際將分別認繳合資公司註冊資本1.16億美元(股權佔比46%)及1260萬美元(股權佔比5%)。此外,旭陽國際投資及旭陽國際亦將在旭陽偉山未能獲得外部項目融資的情況下為旭陽偉山提供股東貸款最高不超過約5.38億美元。旭陽偉山設立後將為集團的附屬公司。
公司表示,本次項目的焦化產品,除了中國境內,也會向IMIP及╱或IMIP工業園內其他企業進行銷售,銷售管道更為快速直接,縮短銷售的地理半徑,加快產銷供的資金鍊回籠,從而擴大集團的投資收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.